BASSAGANYA-RIERA JOSEP (Chairman, President and CEO) sold 1.8% of their position (93.50K shares) of LANDOS BIOPHARMA, INC. on the open market
Open‑market sale worth $456.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/20/2021ACC: 0001843575-21-000010
DirectorOfficer10% Owner· Chairman, President and CEO
Since Feb 2021
-152.15K
Net shares
Net seller
$456.2K
Total sold
3
Open market trades
0B · 3S
4
Total transactions
152.15K disposed
Non-Derivative Transactions4
common stock
Indirect
Shares
−58.65K
Price / share
—
Trade value
—
% of position
1.1%
12/16/2021
5.15M→5.09M
common stock
Indirect
Shares
−24.30K
Price / share
$5.11
Trade value
$124.25K
% of position
0.5%
12/16/2021
5.09M→5.06M
common stock
Indirect
Shares
−36K
Price / share
$4.84
Trade value
$174.10K
% of position
0.7%
12/17/2021
5.06M→5.03M
common stock
Indirect
Shares
−33.19K
Price / share
$4.75
Trade value
$157.80K
% of position
0.7%
12/20/2021
5.03M→4.99M
Total
Net shares
−152.15K
Net value
-$456.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| common stock Indirect | 12/16/2021 | G · Gift | −58.65K | — | — | 1.1% | 5.15M | 5.09M |
| common stock Indirect | 12/16/2021 | S · Sale | −24.30K | $5.11 | $124.25K | 0.5% | 5.09M | 5.06M |
| common stock Indirect | 12/17/2021 | S · Sale | −36K | $4.84 | $174.10K | 0.7% | 5.06M | 5.03M |
| common stock Indirect | 12/20/2021 | S · Sale | −33.19K | $4.75 | $157.80K | 0.7% | 5.03M | 4.99M |
| Total | −152.15K | -$456.15K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
common stock
IndirectShares owned823.96K
common stock
IndirectShares owned766.40K
common stock
IndirectShares owned786.30K
Total
2.38M indirect2.38M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| common stock | 823.96K | Indirect |
| common stock | 766.40K | Indirect |
| common stock | 786.30K | Indirect |
| Total | 2.38M | 2.38M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported